Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 2FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Motor Activity 1Hematologic Neoplasms 1

Interventions

pembrolizumab 3enzalutamide 2Testosterone 2Itraconazole 2Exercise 2zanubrutinib 1venetoclax 1stenoparib 1relugolix 1olaparib 1nilutamide 1ibrutinib 1histrelin 1capivasertib 1bicalutamide 1apalutamide 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1acalabrutinib 1abiraterone 1Waiting Lists 1Triptorelin Pamoate 1Temozolomide 1Surveys and Questionnaires 1Radiosurgery 1Prednisone 1Pluvicto 1PM 01183 1Nutritional Status 1Nivolumab 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × FED × Dosage Forms × Clear all
NCT07058571 2025-07-10

Lifestyle Intervention for Veterans With Blood Cancer: Tele-Intervention

VA Pittsburgh Healthcare System

Phase NA Recruiting
30 enrolled
Other hematologic neoplasm

Motor Activity, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡